ENTITY
D.Western Therapeutics Institute Inc.

D.Western Therapeutics Institute Inc. (4576 JP)

31
Analysis
Health Care • Japan
D.Western Therapeutics Institute Inc.(DWTI) is a biotechnology (bio-venture) company that focuses on development of new drugs. The Company's focus is on protein kinase inhibitors. DWTI discovers and develops several drugs, such as antiglaucoma, antihypertensive, neuroprotective, antithrombogenic, antiatherosclerosis and anticancer.
more
•12 Mar 2026 07:33•Issuer-paid

D. Western Therapeutics Institute (DWTI) (4576 JP) - Q4 Follow-Up - March 3, 2026

The summary of full-year results for D. Western Therapeutics Institute (abbreviated as “DWTI,” hereinafter the “Company”) for FY2025/12 is as follows.

Share
•26 Nov 2025 23:53•Issuer-paid

D. Western Therapeutics Institute (DWTI) (4576 JP) - November 21, 2025

SIR believes DWTI has entered an exciting new phase given significant advances in pipeline development achieved over the last year.

Share
•05 Nov 2025 20:47•Issuer-paid

News Flash: D. Western Therapeutics Institute (4576 JP) - November 5, 2025

DWTI announced after the close on 11/4 that 84.6% of the Series 13 Share Acquisition Rights (with exercise price adjustment clause) issued on July...

Share
•25 Jul 2018 18:44

Japan: Relative Price Score Short Portfolios

RELATIVE PRICE SCORE SHORT PORTFOLIOS - Our recent insight Japan: Most Overbought & Most Oversold - The Relative Price Score introduced our...

Logo
656 Views
Share
•02 Oct 2025 19:46•Issuer-paid

News Flash - D. Western Therapeutics Institute (4576 JP) - October 2, 2025

DWTI announced after the close on 10/1 that 74.0% of the Series 13 Share Acquisition Rights (with exercise price adjustment clause) issued on July...

Share
x